Similar articles

• PET imaging of osteosarcoma.

  Brenner W, Bohuslavizki KH, Eary JF. Brenner W, et al. J Nucl Med. 2003 Jun;44(6):930-42. J Nucl Med. 2003. PMID: 12791822 Review.
• Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique.

  Brunkhorst T, Boerner AR, Bergh S, Otto D, Gratz FW, Knapp WH. Brunkhorst T, et al. Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1416. doi: 10.1007/s00259-002-0964-5. Epub 2002 Aug 20. Eur J Nucl Med Mol Imaging. 2002. PMID: 12271430 No abstract available.
• [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in sarcomas].

  Bourguet P; Groupe de Travail SOR. Bourguet P, et al. Bull Cancer. 2003 Feb;90 Spec No:S96-102. Bull Cancer. 2003. PMID: 12739341 Review. French. No abstract available.
• ¹⁸F-FDG PET/CT in the Management of Osteosarcoma.

  Oh C, Bishop MW, Cho SY, Im HJ, Shulkin BL. Oh C, et al. J Nucl Med. 2023 Jun;64(6):842-851. doi: 10.2967/jnumed.123.265592. Epub 2023 May 18. J Nucl Med. 2023. PMID: 37201958 Review.
• [Contribution of FDG-PET in the management of pediatric sarcomas in 2011].

  Kolesnikov-Gauthier H, Leblond P, Rocourt N, Carpentier P. Kolesnikov-Gauthier H, et al. Bull Cancer. 2011 May;98(5):501-14. doi: 10.1684/bdc.2011.1354. Bull Cancer. 2011. PMID: 21646076 Review. French.